BioSpace News Archive

A global leader in training is helping to build Canada’s best skilled team in healthcare

Apotex Inc. is recalling certain lots because they contain a nitrosamine impurity above the acceptable limit.

Feb. 5, 2020 17:32 UTC LONDON--( BUSINESS WIRE )-- A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article for change leaders in the biosimilars market . This article provides a comprehensive overview of the global biosimilars market and identifies some key trends that players in the sector should capitalize on to succeed.

VALBIOTIS announces the signature of a global long-term strategic partnership with Nestlé Health Science for the development and commercialization of TOTUM-63, an innovative and patented combination of 5 plant extracts specifically designed to reduce the risk of developing Type 2 Diabetes on prediabetics.

Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies addressing high unmet medical needs in the treatment of central nervous system (CNS) disorders, today announced the completion of patient randomization in the pivotal, Phase 3 multicenter trial of roluperidone, its lead product, for the treatment of negative symptoms in schizophrenia.